Pacific Biosciences Price To Book Ratio Over Time

PACB Stock  USD 1.32  0.00  0.00%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Pacific Biosciences Performance and Pacific Biosciences Correlation.
  
The current year's Price To Book Ratio is expected to grow to 4.30.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.58)
Revenue Per Share
0.561
Quarterly Revenue Growth
(0.33)
Return On Assets
(0.12)
Return On Equity
(0.51)
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Price To Book Ratio Analysis

Compare Pacific Biosciences and related stocks such as Twist Bioscience Corp, Intellia Therapeutics, and Crispr Therapeutics Price To Book Ratio Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Capex To DepreciationPb Ratio
RoicInventory Turnover
Net Income Per SharePayables Turnover
Sales General And Administrative To RevenueResearch And Ddevelopement To Revenue
PocfratioInterest Coverage
Capex To Operating Cash FlowPfcf Ratio
Income QualityRoe
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Current RatioReceivables Turnover
Debt To EquityRevenue Per Share
Debt To AssetsDividend Yield
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueEv To Sales
Free Cash Flow Per ShareDays Of Inventory On Hand
Average InventoryCapex To Revenue
Cash Per SharePayout Ratio
Days Payables OutstandingNet Current Asset Value
Tangible Asset ValueNet Debt To E B I T D A
Tangible Book Value Per ShareGraham Number
Shareholders Equity Per ShareCapex Per Share
Graham Net NetAverage Receivables
Interest Debt Per ShareEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Days Of Payables OutstandingDividend Payout Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Enterprise Value Multiple
2010201120122013201420152016201720182019202020212022202320242025
TWST(3.432)(3.432)(3.432)(3.432)(3.432)(3.432)(1.9716)(1.8495)4.31218.8548.88642.40561.84865.54524.995.24
NTLA1.41921.41921.41921.41921.41925.79571.38842.30222.11532.56825.77858.05822.17352.57731.32182.58
CRSP(58.0028)(58.0028)(58.0028)(58.0028)(58.0028)(14.1872)1.06654.99713.49373.52646.06742.39861.68512.6341.71851.8
EDIT(3.1019)(3.1019)(3.1019)(3.1019)(18.377)(7.8174)3.88485.95514.5375.639510.44023.24271.68862.20431.982.08

Pacific Biosciences and related stocks such as Twist Bioscience Corp, Intellia Therapeutics, and Crispr Therapeutics Price To Book Ratio description

A ratio used to compare a firm's market value to its book value, calculated by dividing the current closing price of the stock by the latest quarter's book value per share.

My Equities

My Current Equities and Potential Positions

Pacific Biosciences of
PACB
ClassificationAggressive Defence
LocationCalifornia; U.S.A
ExchangeNASDAQ Exchange
USD 1.32
When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:
Pacific Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Pacific Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pacific Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...